(John Keeble/Getty Images)

Fasten your safety belts

GE Aerospace hits turbulence

Investors are worried about supply-chain snarls in the aircraft industry that could slow engine deliveries.

10/22/24 2:12PM

Jet engine maker GE Aerospace is having its worst daily performance in over two years after its quarterly report undershot Wall Street’s sales estimates.

A key concern for investors appears to be the fact that the company projected that 2024 sales of its super fuel-efficient LEAP engine — used in aircraft like Boeing’s 737 Max, among others — would be down 10%, amid a shaky global aerospace-production outlook hampered by issues like Boeing’s recent machinists’ strike and other supply-chain snafus. Total engine deliveries were down 4% during the third quarter.

After the run-up GE’s shares have had, you can’t blame some for thinking this might be the moment to sell. Just yesterday, the stock was up 91% for the year, making it the sixth-best performer in the S&P 500. Even after today’s tumble investors can still book a roughly 75% gain on the year, which isn’t too shabby.

For the record, other high-flying aerospace stocks — such as Howmet Aerospace, up 90% year to date and due to report numbers early next month — also tumbled Tuesday, seemingly taking a cue from GE’s numbers.

Luke Kawa

13h

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

Nia Warfield, Luke Kawa

14h

S&P 500 falls as rate-cut optimism fizzles

The S&P 500 gave up early gains to close down 0.3%, while the Nasdaq 100 eked out a 0.1% advance and the Russell 2000 outperformed, rising 0.5%.

Nia Warfield

15h

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

RFK Jr., HHS to Link Autism to Tylenol Use in Pregnancy and Folate Deficiencies

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

Max Knoblauch

16h

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Matt Phillips

17h

Palantir slips under 50-day moving average, amid momo reversal

What goes up, doesn’t always keep going up.

Palantir CEO Alex Karp PLTR insane valuation

GE Aerospace hits turbulence

More Markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

RFK Jr., HHS to Link Autism to Tylenol Use in Pregnancy and Folate Deficiencies

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

Latest Stories